In summary, our in vitro study revealed a new mechanism by which NEAT1 regulates cervical cancer progression: NEAT1 promotes aerobic glycolysis in cervical cancer cells to promote the EMT and malignant progression of cervical cancer by activating WNT/β‐catenin/PDK1 axis (Figure 7). The gene discussed is NEAT1; the disease is cervical cancer.